Note: Ingredients listed on restricted chemical lists
EC/CAS
203-473-3/107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
≥40
General Information
Version
2.0
Revision date
2023-10-30
Product name
Opticool Antifreeze Universal Clear
1.2.1 Relevant identified uses
Industrial use,Professional use,Consumer use Industrial/Professional use spec
Manufacturer Name
Exol Lubricants Limited Ltd
Emergency telephone
0344 892 0111
Icons in SDS
Company Information
company name
Exol Lubricants Limited Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
sales@exol-lubricants.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H315, H319, H373
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May cause damage to organs through prolonged or repeated exposure. Harmful if swallowed. Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS08
Signal word
Warning
Contains
ethanediol; ethylene glycol; Potassium 3,5,5-trimethylhexanoate
Hazard statements
H302 - Harmful if swallowed. H315 - Causes skin irritation. H319 - Causes serious eye irritation. H373 - May cause damage to organs through prolonged or repeated exposure.
Precautionary statements
P264 - Wash hands thoroughly after handling. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P501 - Dispose of contents and container to an approved waste disposal plant. P260 - Do not breathe vapours.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
